- Hematopoietic Stem Cell
- Skeletal Muscle Stem Cell
- Mesenchymal Stem Cells
- Lymphocytes
- Others
Personalized Cell Therapies Market size was valued at USD 12,252.24 million in 2022 and is poised to grow at a CAGR of 23.6% from 2023-29. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the market report includes regulatory scenario and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the market report include suppliers, manufacturers, marketers, policymakers engaged in the manufacturing and supply of personalized cell therapies. Research & Development is evolving, various cell types developed into treatments as novel cell therapies due to its potential applications. Bone marrow transplant or hematopoietic stem cell transplant widely used cell therapy due to the treatment of blood cancer. Increased prevalence of cancer, a rise in research and adoption of advanced technologies are expected attract the demand for the market.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
The rise in prevalence of chronic disorders and unmet needs in current treatment methods are expected to catapult the personalized cell therapies market. Increasing prevalence of various disorders such as diabetes, cancer, autoimmune disorders, neurovascular disorders is expected to create demand for personalized cell therapies market over the forecast period. Moreover, potential applications of cell therapies include treating autoimmune disease, cancers, infectious disease, urinary problems, spinal cord injuries, rebuilding damaged cartilage in joints, improving a weakened immune system, neurological disorders are expected to create lucrative opportunities for the market.
The personalized cell therapies market size was valued at USD 12,252.24 million in 2022
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
PCT Cell Therapy Services, LLC (U.S) S. Stem Cell, Inc. (U.S) Bellicum Pharmaceuticals, Inc. (U.S) Saneron CCEL Therapeutics, Inc. (U.S) StemGenex (U.S)
1.Executive Summary |
2.Global Personalized Cell Therapies Market Introduction |
2.1.Global Personalized Cell Therapies Market - Taxonomy |
2.2.Global Personalized Cell Therapies Market - Definitions |
2.2.1.Cell Type |
2.2.2.Application |
2.2.3.Region |
3.Global Personalized Cell Therapies Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Personalized Cell Therapies Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Personalized Cell Therapies Market By Cell Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
5.1. Hematopoietic Stem Cell |
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Skeletal Muscle Stem Cell |
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Mesenchymal Stem Cells |
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Lymphocytes |
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. Others |
5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
6.Global Personalized Cell Therapies Market By Application, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
6.1. Cardiovascular Disorders |
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Diabetes |
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Neurological Disorders |
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Cancer |
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Others |
6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
7.Global Personalized Cell Therapies Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
7.1. North America |
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Europe |
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Asia Pacific (APAC) |
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Middle East and Africa (MEA) |
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Latin America |
7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
8.North America Personalized Cell Therapies Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
8.1. Cell Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.1.1.Hematopoietic Stem Cell |
8.1.2.Skeletal Muscle Stem Cell |
8.1.3.Mesenchymal Stem Cells |
8.1.4.Lymphocytes |
8.1.5.Others |
8.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.2.1.Cardiovascular Disorders |
8.2.2.Diabetes |
8.2.3.Neurological Disorders |
8.2.4.Cancer |
8.2.5.Others |
8.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.3.1.United States of America (USA) |
8.3.2.Canada |
9.Europe Personalized Cell Therapies Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
9.1. Cell Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Hematopoietic Stem Cell |
9.1.2.Skeletal Muscle Stem Cell |
9.1.3.Mesenchymal Stem Cells |
9.1.4.Lymphocytes |
9.1.5.Others |
9.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Cardiovascular Disorders |
9.2.2.Diabetes |
9.2.3.Neurological Disorders |
9.2.4.Cancer |
9.2.5.Others |
9.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Germany |
9.3.2.France |
9.3.3.Italy |
9.3.4.United Kingdom (UK) |
9.3.5.Spain |
9.3.6.Rest of EU |
9.3.7. |
10.Asia Pacific (APAC) Personalized Cell Therapies Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
10.1. Cell Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Hematopoietic Stem Cell |
10.1.2.Skeletal Muscle Stem Cell |
10.1.3.Mesenchymal Stem Cells |
10.1.4.Lymphocytes |
10.1.5.Others |
10.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Cardiovascular Disorders |
10.2.2.Diabetes |
10.2.3.Neurological Disorders |
10.2.4.Cancer |
10.2.5.Others |
10.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.China |
10.3.2.India |
10.3.3.Australia and New Zealand (ANZ) |
10.3.4.Japan |
10.3.5.Rest of APAC |
11.Middle East and Africa (MEA) Personalized Cell Therapies Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
11.1. Cell Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Hematopoietic Stem Cell |
11.1.2.Skeletal Muscle Stem Cell |
11.1.3.Mesenchymal Stem Cells |
11.1.4.Lymphocytes |
11.1.5.Others |
11.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Cardiovascular Disorders |
11.2.2.Diabetes |
11.2.3.Neurological Disorders |
11.2.4.Cancer |
11.2.5.Others |
11.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.GCC Countries |
11.3.2.South Africa |
11.3.3.Rest of MEA |
12.Latin America Personalized Cell Therapies Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
12.1. Cell Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Hematopoietic Stem Cell |
12.1.2.Skeletal Muscle Stem Cell |
12.1.3.Mesenchymal Stem Cells |
12.1.4.Lymphocytes |
12.1.5.Others |
12.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Cardiovascular Disorders |
12.2.2.Diabetes |
12.2.3.Neurological Disorders |
12.2.4.Cancer |
12.2.5.Others |
12.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Brazil |
12.3.2.Mexico |
12.3.3.Rest of LA |
13. Competition Landscape |
13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
13.2.1.PCT Cell Therapy Services, LLC (U.S) |
13.2.2.S. Stem Cell, Inc. (U.S) |
13.2.3.Bellicum Pharmaceuticals, Inc. (U.S) |
13.2.4.Saneron CCEL Therapeutics, Inc. (U.S) |
13.2.5.StemGenex (U.S) |
13.2.6.Vericel Corporation.(U.S) |
13.2.7.Cytori Therapeutics Inc.(U.S.) |
13.2.8.MolMed S.p.A. (Italy) |
14. Research Methodology |
15. Appendix and Abbreviations |